Key Record Dates
ClinicalTrials.gov Identifier: | NCT02628067 |
---|---|
Brief Title: | Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) |
First Submitted : | December 9, 2015 |
First Submitted that Met QC Criteria : | December 9, 2015 |
First Posted : | December 11, 2015 (Estimate) |
Last Update Submitted that Met QC Criteria : | May 9, 2024 |
Last Update Posted : | May 10, 2024 (Estimate) |